Valeant Pharmaceuticals To Present At Health Care Conferences

May 10, 2017

LAVAL, Quebec, May 10, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that Joseph C. Papa, chairman and chief executive officer, is scheduled to present at the following health care conferences:

  • Bank of America Merrill Lynch 2017 Healthcare Conference on Wednesday, May 17, 2017 at 3:00 p.m. PDT (6:00 p.m. EDT) at the Wynn Las Vegas hotel;
  • UBS Global Healthcare Conference to be held on Monday, May 22, 2017 at 9:00 a.m. EDT at the Grand Hyatt New York hotel; and
  • Jefferies 2017 Global Healthcare Conference to be held on Wednesday, June 7, 2017 at 8:30 a.m. EDT at the Grand Hyatt New York hotel.

A live webcast and audio archive of the events will be available on Valeant's Investor Relations website and via this URL: http://ir.valeant.com/events-and-presentations

About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant and forward looking statements can be found at www.valeant.com.

Contact Information
Investors:
Elif McDonald
elif.mcdonald@valeant.com
514-856-3855
877-281-6642 (toll free)

Media:
Lainie Keller
lainie.keller@valeant.com
908-927-0617

Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.) (PRNewsFoto/)

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/valeant-pharmaceuticals-to-present-at-health-care-conferences-300455523.html

SOURCE Valeant Pharmaceuticals International, Inc.